Polypropylene meshes are standard for hernia repair. Matrix metalloproteinases play a central role in inflammation. To reduce the inflammatory response and improve remodelling with an associated reduction of hernia recurrence, we modified polypropylene meshes by nanofibre coating and saturation with the broad-spectrum matrix metalloproteinase inhibitor GM6001. The aim was to modulate the inflammatory reaction, increase collagen deposition and improve mesh biointegration. Polypropylene meshes were surface-modified with star-configured NCO-sP(EO-stat-PO) and covered with electrospun nanofibres (polypropylene-nano) and GM6001 (polypropylene-nano-GM). In a hernia model, defects were reconstructed with one of the meshes. Inflammation, neovascularization, bio-integration, proliferation and apoptosis were assessed histologically, collagen content and gelatinases biochemically. Mesh surface modification resulted in higher inflammatory response compared to polypropylene. Pro-inflammatory matrix metalloproteinase-9 paralleled findings while GM6001 reduced matrix metalloproteinase-9 significantly. Significantly increased matrix metalloproteinase-2 beneficial for remodelling was noted with polypropylene-nano-meshes. Increased vascular endothelial growth factor, neo-vascularization and collagen content were measured in polypropylene-nano-meshes compared to polypropylene. GM6001 significantly reduced myofibroblasts. This effect ended after d14 due to engineering limitations with release of maximal GM6001 loading. Nanofibre-coating of polypropylene-meshes confers better tissue vascularization to the cost of increased inflammation. This phenomenon can be only partially compensated by GM6001. Future research will enable higher GM6001 uptake in nano-coated meshes and may alter mesh biointegration in a more pronounced way.
KingsnorthAN. Epidemiology, pathogenesis, and natural history. In: Schumpelick V and Wantz GE (eds) Inguinal hernia repair. Basel: Karger, 1995, pp.2–5.
2.
SimonsMPAufenackerTBay-NielsenMet al.
European Hernia Society guidelines on the treatment of inguinal hernia in adult patients. Hernia2009;
13: 343–403.
3.
EUHT Collaboration.
Repair of groin hernia with synthetic mesh: meta-analysis of randomized controlled trials. Ann Surg2002;
235: 322–332.
4.
MannDVProutJHavranekEet al.
Late-onset deep prosthetic infection following mesh repair of inguinal hernia.Am J Surg1998;
176: 12–14.
5.
ShellDHde la TorreJAndradesPet al.
Open repair of ventral incisional hernias.Surg Clin North Am2008;
88: 61–83, viii.
6.
KlosterhalfenBJungeK andKlingeU.The lightweight and large porous mesh concept for hernia repair.Exp Rev Med Dev2005;
2: 103–117.
7.
BohmGUshakovaYAlizaiHPet al.
Biocompatibility of PLGA/sP(EO-stat-PO)-coated mesh surfaces under constant shearing stress. Eur Surg Res2011;
47: 118–129.
8.
NovitskyYWHarrellAGCristianoJAet al.
Comparative evaluation of adhesion formation, strength of ingrowth, and textile properties of prosthetic meshes after long-term intra-abdominal implantation in a rabbit. J Surg Res2007;
140: 6–11.
9.
FetNAlizaiPHFragoulisAet al.
In vivo characterisation of the inflammatory reaction following mesh implantation in transgenic mice models.Langenbeck’s Archiv Surg/Deutsche Gesellschaft fur Chirurgie2014;
399: 579–588.
10.
BinneboselMvon TrothaKTRickenCet al.
Gentamicin supplemented polyvinylidenfluoride mesh materials enhance tissue integration due to a transcriptionally reduced MMP-2 protein expression.BMC Surg2012;
12: 1–9.
11.
FaulkDMLondonoRWolfMTet al.
ECM hydrogel coating mitigates the chronic inflammatory response to polypropylene mesh.Biomaterials2014;
35: 8585–8595.
12.
BlazquezRSanchez-MargalloFMAlvarezVet al.
Surgical meshes coated with mesenchymal stem cells provide an anti-inflammatory environment by a M2 macrophage polarization.Acta Biomater2016;
31: 221–230.
13.
GuillaumeOTeuschlAHGruber-BlumSet al.
Emerging trends in abdominal wall reinforcement: Bringing bio-functionality to meshes.Adv Healthcare Mater2015;
4: 1763–1789.
14.
HolzapfelBMReichertJCSchantzJTet al.
How smart do biomaterials need to be? A translational science and clinical point of view.Adv Drug Deliv Rev2013;
65: 581–603.
15.
PatelAMukundanSWangWet al.
Carbon-based hierarchical scaffolds for myoblast differentiation: Synergy between nano-functionalization and alignment.Acta Biomater2016;
32: 77–88.
BruellhoffKFiedlerJMollerMet al.
Surface coating strategies to prevent biofilm formation on implant surfaces.Int J Artif Organs2010;
33: 646–653.
18.
LiuLZhouXXuYet al.
Controlled release of growth factors for regenerative medicine.Curr Pharm Des2015;
21: 1627–1632.
19.
Bracho-SanchezEXiaCQClare-SalzlerMJet al.
Micro and nano material carriers for immunomodulation.Am J Transplant2016; 16(12): 3362–3370.
20.
Rodriguez-VelazquezEAlatorre-MedaM andManoJF.Polysaccharide-based nanobiomaterials as controlled release systems for tissue engineering applications.Curr Pharm Des2015;
21: 4837–4850.
21.
OlivaNUntermanSZhangYet al.
Personalizing biomaterials for precision nanomedicine considering the local tissue microenvironment.Adv Healthcare Mater2015;
4: 1584–1599.
22.
DasRK andZouaniOF.A review of the effects of the cell environment physicochemical nanoarchitecture on stem cell commitment.Biomaterials2014;
35: 5278–5293.
23.
BinneboselMKlinkCDOttoJet al.
Impact of mesh positioning on foreign body reaction and collagenous ingrowth in a rabbit model of open incisional hernia repair. Hernia2010;
14: 71–77.
24.
JungeKRoschRBialasinskiLet al.
Persistent extracellular matrix remodelling at the interface to polymers used for hernia repair.Eur Surg Res2003;
35: 497–504.
25.
RoschRJungeKSchachtruppAet al.
Mesh implants in hernia repair. Inflammatory cell response in a rat model.Eur Surg Res2003;
35: 161–166.
26.
EmingSAKriegT andDavidsonJM.Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol2007;
127: 514–525.
27.
WernerS andGroseR.Regulation of wound healing by growth factors and cytokines.Physiol Rev2003;
83: 835–870.
28.
RoschRLynen-JansenPJungeKet al.
Biomaterial-dependent MMP-2 expression in fibroblasts from patients with recurrent incisional hernias.Hernia2006;
10: 125–130.
29.
AntoniouSAAntoniouGAGranderathFAet al.
The role of matrix metalloproteinases in the pathogenesis of abdominal wall hernias.Eur J Clin Invest2009;
39: 953–959.
30.
AgrenMSSchnabelRChristensenLHet al.
Tumor necrosis factor-alpha-accelerated degradation of type I collagen in human skin is associated with elevated matrix metalloproteinase (MMP)-1 and MMP-3 ex vivo. Eur J Cell Biol2015;
94: 12–21.
31.
ParksWCWilsonCL andLopez-BoadoYS.Matrix metalloproteinases as modulators of inflammation and innate immunity.Nat Rev Immunol2004;
4: 617–629.
32.
ParksWC.Matrix metalloproteinases in repair.Wound Repair Regen1999;
7: 423–432.
33.
Guillen-MartiJDiazRQuilesMTet al.
MMPs/TIMPs and inflammatory signalling de-regulation in human incisional hernia tissues.J Cell Mol Med2009;
13: 4432–4443.
34.
WoessnerJF andNagaseH.Matrix metalloproteinases and TIMPs.
New York:
Oxford University of Press, 2000.
35.
WoessnerJFJr.Matrix metalloproteinase inhibition. From the Jurassic to the third millennium.Ann NY Acad Sci1999;
878: 388–403.
GalardyREGrobelnyDFoellmerHGet al.
Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl)]-L-tryptophan methylamide. Cancer Res1994;
54: 4715–4718.
MirastschijskiUSchnabelRClaesJet al.
Matrix metalloproteinase inhibition delays wound healing and blocks the latent transforming growth factor-beta1-promoted myofibroblast formation and function.Wound Repair Regen2010;
18: 223–234.
40.
RehnMKrarupPMChristensenLHet al.
GM6001 increases anastomotic leakage following colonic obstruction possibly by impeding epithelialization.Surg Infect2015;
16: 702–708.
41.
MirastschijskiUJohannessonKJeppssonBet al.
Effect of a matrix metalloproteinase activity and TNF-alpha converting enzyme inhibitor on intra-abdominal adhesions.Eur Surg Res2005;
37: 68–75.
42.
LeibSLLeppertDClementsJet al.
Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.Infect Immun2000;
68: 615–620.
43.
FriedlP.Dynamic imaging of cellular interactions with extracellular matrix.Histochem Cell Biol2004;
122: 183–190.
44.
MirastschijskiUImpolaUKarsdalMAet al.
Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo. JInvest Dermatol2002;
118: 55–64.
45.
SalberJGraterSHarwardtMet al.
Influence of different ECM mimetic peptide sequences embedded in a nonfouling environment on the specific adhesion of human-skin keratinocytes and fibroblasts on deformable substrates.Small2007;
3: 1023–1031.
46.
GasteierPReskaASchultePet al.
Surface grafting of PEO-based star-shaped molecules for bioanalytical and biomedical applications.Macromol Biosci2007;
7: 1010–1023.
47.
JunqueiraLCCossermelliW andBrentaniR.Differential staining of collagens type I, II and III by Sirius Red and polarization microscopy.Archivum Histologicum Japonicum = Nihon Soshikigaku Kiroku1978;
41: 267–274.
48.
JungeKKlingeURoschRet al.
Decreased collagen type I/III ratio in patients with recurring hernia after implantation of alloplastic prostheses. Langenbeck's Archiv Surg/Deutsche Gesellschaft fur Chirurgie2004;
389: 17–22.
49.
JungeKKlingeURoschRet al.
Functional and morphologic properties of a modified mesh for inguinal hernia repair.World J Surg2002;
26: 1472–1480.
50.
EUHT Collaboration.
Mesh compared with non-mesh methods of open groin hernia repair: systematic review of randomized controlled trials. Br J Surg2000;
87: 854–859.
HelgstrandF andJorgensenLN.The Danish Ventral Hernia Database - a valuable tool for quality assessment and research.Clin Epidemiol2016;
8: 719–723.
53.
SalataO.Applications of nanoparticles in biology and medicine.J Nanobiotechnol2004;
2: 1–6.
54.
MartindaleRG andDeveneyCW.Preoperative risk reduction: strategies to optimize outcomes.Surg Clin North Am2013;
93: 1041–1055.
55.
WernerMU.Management of persistent postsurgical inguinal pain.Langenbeck's Archiv Surg/Deutsche Gesellschaft fur Chirurgie2014;
399: 559–569.
56.
SaghatelianAJessaniNJosephAet al.
Activity-based probes for the proteomic profiling of metalloproteases.Proc Natl Acad Sci USA2004;
101: 10000–10005.
57.
GrobelnyDPonczL andGalardyRE.Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids.Biochemistry1992;
31: 7152–7154.
58.
BendeckMPIrvinC andReidyMA.Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury.Circ Res1996;
78: 38–43.
59.
AgrenMSAndersenTLAndersenLet al.
Nonselective matrix metalloproteinase but not tumor necrosis factor-alpha inhibition effectively preserves the early critical colon anastomotic integrity. Int J Colorect Dis2011;
26: 329–337.
SchultzGSStrelowSSternGAet al.
Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases. Invest Ophthalmol Vis Sci1992;
33: 3325–3331.
62.
GearingAJBeckettPChristodoulouMet al.
Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature1994;
370: 555–557.
63.
LiuZFengXWangHet al.
Carbon nanotubes as VEGF carriers to improve the early vascularization of porcine small intestinal submucosa in abdominal wall defect repair. Int J Nanomed2014;
9: 1275–1286.
64.
TorisevaM andKahariVM.Proteinases in cutaneous wound healing.Cell Mol Life Sci2009;
66: 203–224.
65.
HeljasvaaraRNybergPLuostarinenJet al.
Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.Exp Cell Res2005;
307: 292–304.
66.
WuM-P.Regulation of extracellular matrix remodeling associated with pelvic organ prolapse.J Exp Clin Med2010;
2: 11–16.
67.
PrudenteAFavaroWJLatufPFet al.
Host inflammatory response to polypropylene implants: insights from a quantitative immunohistochemical and birefringence analysis in a rat subcutaneous model.Int Braz J Urol2016;
42: 585–593.
68.
BellonJMBajoAGa-HonduvillaNet al.
Fibroblasts from the transversalis fascia of young patients with direct inguinal hernias show constitutive MMP-2 overexpression. Ann Surg2001;
233: 287–291.
69.
JacksonSRAveryNCTarltonJFet al.
Changes in metabolism of collagen in genitourinary prolapse.Lancet1996;
347: 1658–1661.
70.
SakalihasanNDelvennePNusgensBVet al.
Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms.J Vasc Surg1996;
24: 127–133.
71.
ChangCHHuangYLShyuMKet al.
Sphingosine-1-phosphate induces VEGF-C expression through a MMP-2/FGF-1/FGFR-1-dependent pathway in endothelial cells in vitro. Acta Pharmacol Sin2013;
34: 360–366.
72.
TholozanFMGribbonCLiZet al.
FGF-2 release from the lens capsule by MMP-2 maintains lens epithelial cell viability.Mol Biol Cell2007;
18: 4222–4231.
